Drug Topics staff

Check out this list of our 10 most read stories from April 2024.

Check out these important FDA updates from the month of April 2024.

Check out these featured Drug Topics expert interviews from April 2024.

Your weekly roundup of the latest news from Drug Topics®.

Your weekly roundup of the latest news from Drug Topics®.

Your weekly roundup of the latest news from Drug Topics®.

Your weekly roundup of the latest news from Drug Topics®.

Your monthly roundup of the top news from Drug Topics®.

Your weekly roundup of the latest news from Drug Topics®.

Be sure to vote in this month's poll!

WHO ends COVID-19 public health emergency, privacy concerns around mental health apps, and astronomical interest with medical credit cards.

Lawmakers take on harm reduction, in-flight medical emergency kits are under review, and a new Alzheimer drug shows promise.

With the respiratory season in full swing and COVID-19 continuing to infect, knowing the basics of the common cold, influenza, COVID-19, and respiratory syncytial virus can help ensure patients get the right care.

Criteria and types of health care professionals who may screen patients at high risk for cardiovascular disease.

Recommendations for establishing relationships and talking with patients about primary and secondary prevention against cardiovascular events.

The FDA has granted emergency use authorization status for the first single-dose vaccine for COVID-19 in the United States.

Here are some of the top-read FDA approvals covered by Drug Topics® from this year.

The Drug Topics® team rounded up some of our top-read articles from the last year.

Independent pharmacists should tune in to this webinar event to learn how Good Neighbor Pharmacy's 4 core value centers can help them optimize their business.

Here's the coronavirus-related news from this week that you should know. 

Here's the roundup for this week's coronavirus-related news.

Here's the coronavirus-related news from this week that you should know.

Here's this week's roundup of the coronavirus-related news you should know.

Heidi Polek, strategic program manager at DrFirst, discusses with Drug Topics the impact that the COVID-19 pandemic is having on chronic conditions and medication adherence.

Here's this week's coronavirus-related news you should know.

Here's this week's coronavirus-related news.

Here's the coronavirus-related news from this week that you should know.

Here's this week's coronavirus-related news that you should know.

Here's the coronavirus-related news from this week that you should know.

Here's this week's coronavirus-related news you should know.